Legal Opinion

In Re Diet Drugs

Court of Appeals for the Third Circuit

Decided October 8, 2009No. 08-2387PublishedCited by 102 opinions

1Opinion of the Court

OPINION OF THE COURT

JORDAN, Circuit Judge.

Three law firms and some of their clients challenge the final award of attorneys’ fees that the United States District Court for the Eastern District of Pennsylvania entered on behalf of class counsel in this landmark class action. For the following reasons, we will affirm the award.

I. Background

A. Diet Drugs Litigation and Settlement

This appeal arises from multidistrict mass tort litigation concerning the appetite suppressants fenfluramine, marketed as “Pondimin,” and dexfenfluramine, marketed as “Redux.” Over its decade-long course, the case1 has…

2Cases cited38 opinions

  1. Alyeska Pipeline Service Co. v. Wilderness SocietySupreme Court of the United States · 1975
  2. White v. New Hampshire Department of Employment SecuritySupreme Court of the United States · 1982
  3. Hall v. ColeSupreme Court of the United States · 1973
  4. Boeing Co. v. Van GemertSupreme Court of the United States · 1980
  5. In Re: The Prudential Insurance Company Of America Sales Practices LitigationCourt of Appeals for the Third Circuit · 1998

33 more not listed; retrieve them via the Exa API.

3Cited by102 opinions

  1. Sullivan v. DB Investments, Inc.Court of Appeals for the Third Circuit · 2011
  2. In Re National Football League Players Concussion Injury LitigationCourt of Appeals for the Third Circuit · 2016
  3. In Re Baby Products Antitrust LitigationCourt of Appeals for the Third Circuit · 2013
  4. Lance v. WyethSupreme Court of Pennsylvania · 2014
  5. In re National Football League Players' Concussion Injury LitigationDistrict Court, E.D. Pennsylvania · 2015

97 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API